» Articles » PMID: 28972186

Intramolecular Autoinhibition of Checkpoint Kinase 1 is Mediated by Conserved Basic Motifs of the C-terminal Kinase-associated 1 Domain

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2017 Oct 4
PMID 28972186
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Precise control of the cell cycle allows for timely repair of genetic material prior to replication. One factor intimately involved in this process is checkpoint kinase 1 (Chk1), a DNA damage repair inducing Ser/Thr protein kinase that contains an N-terminal kinase domain and a C-terminal regulatory region consisting of a ∼100-residue linker followed by a putative kinase-associated 1 (KA1) domain. We report the crystal structure of the human Chk1 KA1 domain, demonstrating striking structural homology with other sequentially diverse KA1 domains. Separately purified Chk1 kinase and KA1 domains are intimately associated in solution, which results in inhibition of Chk1 kinase activity. Using truncation mutants and site-directed mutagenesis, we define the inhibitory face of the KA1 domain as a series of basic residues residing on two conserved regions of the primary structure. These findings point to KA1-mediated intramolecular autoinhibition as a key regulatory mechanism of human Chk1, and provide new therapeutic possibilities with which to attack this validated oncology target with small molecules.

Citing Articles

CHK1 controls zygote pronuclear envelope breakdown by regulating F-actin through interacting with MICAL3.

Zhang H, Cui Y, Yang B, Hou Z, Zhang M, Su W EMBO Rep. 2024; 25(11):4876-4897.

PMID: 39358552 PMC: 11549291. DOI: 10.1038/s44319-024-00267-7.


Spatiotemporal regulation of MELK during mitosis.

Majumdar S, Liu S Front Cell Dev Biol. 2024; 12:1406940.

PMID: 39355119 PMC: 11443572. DOI: 10.3389/fcell.2024.1406940.


DEAD box RNA helicases are pervasive protein kinase interactors and activators.

Hirth A, Fatti E, Netz E, Acebron S, Papageorgiou D, Svorinic A Genome Res. 2024; 34(6):952-966.

PMID: 38986579 PMC: 11293542. DOI: 10.1101/gr.278264.123.


Case report: A germline leads to a splicing error in a family with multiple cancer patients.

Qian J, Peng M, Li Y, Liu W, Zou X, Chen H Front Oncol. 2024; 14:1380093.

PMID: 38686193 PMC: 11056527. DOI: 10.3389/fonc.2024.1380093.


The Adaptive Mechanisms and Checkpoint Responses to a Stressed DNA Replication Fork.

Saldanha J, Rageul J, Patel J, Kim H Int J Mol Sci. 2023; 24(13).

PMID: 37445667 PMC: 10341514. DOI: 10.3390/ijms241310488.


References
1.
Zhang Y, Lai J, Du Z, Gao J, Yang S, Gorityala S . Targeting radioresistant breast cancer cells by single agent CHK1 inhibitor via enhancing replication stress. Oncotarget. 2016; 7(23):34688-702. PMC: 5085184. DOI: 10.18632/oncotarget.9156. View

2.
Palermo C, Hope J, Freyer G, Rao H, Walworth N . Importance of a C-terminal conserved region of Chk1 for checkpoint function. PLoS One. 2008; 3(1):e1427. PMC: 2173936. DOI: 10.1371/journal.pone.0001427. View

3.
Emptage R, Lemmon M, Ferguson K . Molecular determinants of KA1 domain-mediated autoinhibition and phospholipid activation of MARK1 kinase. Biochem J. 2016; 474(3):385-398. PMC: 5317272. DOI: 10.1042/BCJ20160792. View

4.
Rundle S, Bradbury A, Drew Y, Curtin N . Targeting the ATR-CHK1 Axis in Cancer Therapy. Cancers (Basel). 2017; 9(5). PMC: 5447951. DOI: 10.3390/cancers9050041. View

5.
Han X, Tang J, Wang J, Ren F, Zheng J, Gragg M . Conformational Change of Human Checkpoint Kinase 1 (Chk1) Induced by DNA Damage. J Biol Chem. 2016; 291(25):12951-9. PMC: 4933214. DOI: 10.1074/jbc.M115.713248. View